Table 3.

Use of antibiotic prophylaxis and screening for S. aureus among facilities in PDOPPS (percentage within country)

Facility characteristics	ANZ	Canada	Japan	Thailand	UK	USA
Number of facilities	18	20	28	22	17	65
Procedures/situations where antibiotic prophylaxis is used or recommended at your center:
1. PD catheter insertion, %	83	100	89	86	100	63
2. Nonsurgical PD catheter manipulation, %	47	60	29	32	62	33
3. Routine dental procedures, %	22	35	7	29	0	51
4. Complicated dental procedures, %	61	70	68	43	24	83
5. Gynecological procedures, %	53	40	32	48	53	65
6. Genitourinary procedures, %	47	35	41	45	47	53
7. Upper gastrointestinal endoscopy, %	17	25	7	36	0	31
8. Lower gastrointestinal endoscopy, %	61	65	36	40	77	66
9. Wet contaminationa, %	94	90	68	68	88	91
No antibiotic use for procedures 3–8, %	35	25	12	42	12	10
Routinely screen patients for nasal carriage of S. aureus, %
Yes, only once	22	10	18	5	12	6
Yes, on a recurrent basis in patients previously identified as carriers	22	5	4	0	6	6
Yes, on recurrent basis in all patients	28	25	0	0	59	6
Never	28	60	79	96	24	81
Eradicate S. aureus carriage with intranasal mupirocin, %	92	63	33	0	92	80

^aWet contamination includes disconnection between the transfer set and the catheter at the connector, a hole in the transfer set or the catheter or accidental opening of the transfer set and escape of PD fluid.